BANGKOK, THAILAND, DEC.20, 2017 -- TESSLIFT CO., LTD., a leading provider of tissue approximation technologies for Plastic & Reconstruction markets, has underwent a succesful launching symposium with the help of its Thailand Exclusive Distributor. As the No.1 Aesthetic Medicine distributor, it has formulated conference at TRIA BEAUTY CLINIC, Bangkok to educate and provide hands-on training to the medical professionals and marketers before the imminent launch of the TESSLIFT SOFT in Thailnad. With the network of more than 500 clinics in Thailand, Myanmar, and Cambodia, the distributor has demonstrated an exponential degree of marketing force over the ASEAN countries. Furthermore, the distributor will supply to and market via its own brand of clinics located in Thailand and Myanmar. The company comprises 150 and more employees who are young and dyanmic. "They never stop marketing and searching for new innovations," said Jimmy JW Kim, the CEO of ZISHEL GROUP.
TESSLIFT, the premium mesh implant, is deployed into the SMAS layers to suspend the surrounding tissues via tissue ingrowths technology into its pores. The barbs in the implant provides the initial holding strength to suspend the tissues. The mesh and its tissue ingrowth of the surrounding tissues provide the major contributions in the later phases. This world's first innovative technology is protected under the intellectual property rights in over 48 countries.
ABOUT ZISHEL GROUP
ZISHEL GROUP is established to R&D, market, and distribute the novel medical technologies for Plastic and Reconstruction and Aesthetics. In connection with more than 23 international medical chains and +11450 private clinics, we have the mega-size distribution channels in over 52 countries covered by +35 blockbuster distributors worldwide. The majority of our executives were both educated and trained in the United States. They lead with excellence via unique leadership styles over our staffs and have propitious relationships with internationally recognized professors, physicians, and healthcare professionals worldwide. Our key differentiator is our continual investments for R&D activities under variety of applications. In the fast-changing healthcare environment, we challenge ourselves to adapt to new trends and lead developments for novel solutions tailored to our clients' needs.
WEBSITE. www.zishel.com | EMAIL. firstname.lastname@example.org
TESSLIFT is a privately owned medical device company, dedicated to the development and commercialization of the world's first invented mesh suspension implants. TESS is an abbreviation for Tissue Elevation Suspension System. For research initiatives underway, we desire to use our novel technology to expand its use to meet other unmet clinical needs. With that in mind, we are closely cooperating with surgeons and biomedical engineers to maximize the safety and effectiveness of our products.
WEBSITE. www.tesslift.com | EMAIL. email@example.com
EILEEN KIM, ZISHEL GROUP
CONTACT. +1-851-0186 [US]